Related Experiment Video
Updated: Jun 7, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins withdrawal, vascular complications, rebound effect and similitude
1Department of Internal Medicine, Universidade de São Paulo, Brazil. marcus@homeozulian.med.br
Homeopathy : the Journal of the Faculty of Homeopathy
|October 26, 2010
Summary
The rebound effect observed when discontinuing statin therapy mirrors Hahnemann's secondary drug action. This vital reaction in patients with vascular disease highlights a principle used in homeopathic medicine.
Area of Science:
- Homeopathic medicine
- Pharmacology
- Cardiovascular disease
Background:
- Samuel Hahnemann's concept of secondary drug action.
- The rebound effect of modern medications.
- Widespread use of statins for cardiovascular disease prevention.
Purpose of the Study:
- To review evidence of statin rebound effects.
- To support the similitude principle with statin data.
- To link statin rebound to Hahnemann's secondary action.
Main Methods:
- Literature review of statin rebound effects.
- Analysis of studies on cardiovascular outcomes after statin cessation.
- Comparison of observed rebound phenomena with homeopathic principles.
Main Results:
- Statin suspension leads to impaired vascular function.
- Discontinuation of statins increases morbidity and mortality in vascular patients.
- Statin rebound effects align with Hahnemann's secondary action concept.
Conclusions:
- The rebound effect of statins supports Hahnemann's secondary action principle.
- Homeopathy utilizes secondary drug actions therapeutically.
- Understanding rebound effects can inform clinical practice and homeopathic principles.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...